Biotech ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds Celsion Corporation Investors of Important December 29 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – CLSN December 22, 2020
Biotech LEADING ROSEN LAW FIRM Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – FBIO December 22, 2020
Biotech Advaxis Announces Listing Transfer to Nasdaq Capital Market and Additional 180-day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule December 22, 2020
Biotech Cerecor Announces FDA Acceptance of Investigational New Drug Application for CERC-007 for the Treatment of Still’s Disease December 22, 2020
Biotech Acer Therapeutics Announces Full Enrollment of Pivotal Bioequivalence Trial of ACER-001 for Urea Cycle Disorders December 22, 2020
Biotech Cocrystal Pharma Selects Lead Compound for Further Development Against Coronaviruses December 22, 2020
Biotech Cyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn Bioventures December 22, 2020
Search
Biotech
December 22, 2020
December 22, 2020
December 22, 2020
December 22, 2020
December 22, 2020
December 22, 2020
December 22, 2020
December 22, 2020
December 22, 2020
December 22, 2020
